Foundation for the Advancement of Stem Cell Regenerative Medicine Research, Inc.
300 West 14th Street
New York, NY
10014
Founded by orthopedic trauma surgeon and stem cell researcher Brian Mehling, M.D., the Foundation for the Advancement of Stem Cell and Regenerative Medicine Research, Inc. is an independent, tax-exempt, 501 ( c ) (3) charitable organization whose goal is to employ scientists and researchers to seek grants and participate in clinical trial to further the use of stem cell therapy and regenerative medicine.
Foundation Mission: The Foundation for the Advancement of Stem Cell and Regenerative Medicine, Inc. assists in and finances the advancement of all aspects of stem cell therapies and cellular regenerative medicine and research in full regulatory conformance, in conjunction with the international scientific community. The foundation will also raise awareness and provide education to the medical, scientific, and lay communities.
About Us:
Stem cell therapy has successfully proven to regenerate the human body without the need for medicine and surgery. Patients suffering from chronic, often debilitating diseases can benefit, including those diagnosed with Alzheimer’s disease, strokes, diabetes, arthritis, heart disease, infertility, erectile dysfunction and chronic traumatic encephalopathy, the neurodegenerative disease found in people with multiple head injuries. Our foundation is led by an accomplished scientific and medical team and draws on its relationship with international partners who have successfully treated thousands of patients with stem cell therapy.
Our team has conducted clinical investigations in collaboration with local partners in Slovakia and China, to evaluate the safety and efficacy of adult stem cells as a regenerative medicine for use in the treatment of chronic inflammation, musculoskeletal conditions, stroke, spinal cord injury and other medical conditions.
Grants and Publications:
Our team of researchers and scientific writers diligently works on new protocols and grant applications to conduct new trials.
The expansion of our protocols has been an ongoing effort. There are
currently 58 protocols for diseases that fall under various
categories including Neurological, Orthopedic, and Peripheral.
We also actively seek out grant opportunities. These grants are sponsored by different agencies in the United States such as the National Institutes of Health, the Department of Defense, and the VA. Our goal is to expand our grant applications internationally.
The team is working on our Traumatic Brain Injury and PTSD
investigational new drug applications (IND). It is our hope to provide
these therapies to our veterans who deserve access to these new
treatments.
Our published research is available here.
Foundation Board Members:
Brian Mehling, MD
Doreen Santora
Dr. Adam Bader
Chief Executive Officer/ Chief Operating Officer
American Academy of Cosmetic Surgery Hospital
Vicky Yamamoto, Ph.D.
Cancer Scientist
USC Norris Comprehensive Cancer Center
Keck School of Medicine of USC
Dr. Mohamed Ismail
American Academy Cosmetic Surgery Hospital